Automotive Semiconductor Market Forecast 2028 Top Companies, Trends and Growth Factors Details for Business Development

 Automotive Semiconductor Market Growth & Trends

The global automotive semiconductor market size is expected to reach USD 63.92 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.2% from 2021 to 2028. The growing focus on vehicle safety systems and a significant increase in the adoption of engine control units (ECUs) in modern automobiles are anticipated to drive the demand for automotive semiconductors. Moreover, emerging technologies such as 5G and IoT are expected to play an instrumental role in increasing the demand for automotive semiconductors. Additionally, electric vehicles and all levels of assisted driving technologies are expected to create considerable growth opportunities over the next eight years.

Electrification in the automotive industry is growing rapidly owing to the rising need to reduce carbon emissions. Having realized the importance of electric vehicle business opportunities, several manufacturers are increasingly investing in smart technologies, electronics, and safety systems. Such components of electric vehicles comprise semiconductors equipped with advanced technologies to improve the functionalities of smart electronics. For instance, the application of shock sensors, MEMS accelerometers, MEMS gyroscopes, inertial sensors, tilt sensors, and MEMS microphones for roll over detection, electronic braking, dynamic head lighting, inertial navigation, and airbag safety systems. Hence, as the demand for hybrid and electric vehicles increases, the need for semiconductors is anticipated to increase over the forecast period.

The outbreak of the COVID-19 pandemic hampered the overall business scenario in 2020, and the economy is expected to continue experiencing its aftermath over the next few years. The market witnessed a negative impact as major automotive fabricating units were shut and their production was completely halted in response to lockdown measures across the world. Additionally, the pandemic caused an unrealistic disturbance in the production and supply chain network. This influenced R&D and capital investments. The market experienced a substantial decline, of nearly -7.0%, in 2020. However, the impact of the pandemic started reducing with the reduction in positive cases and the launch of vaccination campaigns across several countries. As a result, governments across the globe eased the lockdowns and restrictions, thereby leading to a restart in manufacturing operations in the automotive semiconductor industry.

Safety guidelines and regulations imposed by governments are expected to play a key role in driving the demand for semiconductors in North American and European markets. For instance, a special focus on accident avoidance through ADAS is expected to help drive market growth in countries across these regions. The Asia Pacific region, led by China, is projected to emerge as the fastest-growing market owing to rapid EV adoption and strong government support.

Request a free sample copy or view report summary: Automotive Semiconductor Market Report

Automotive Semiconductor Market Report Highlights

• In 2020, the others component segment, which includes analog ICs and logic ICs, accounted for the highest share as logic ICs are widely used in navigation and infotainment systems
• In terms of vehicle type, passenger vehicle emerged as the dominant segment in 2020 and is anticipated to retain its dominance over the forecast period
• The telematics and infotainment segment is projected to expand at the highest CAGR of more than 9.0% over the forecast period and is anticipated to hold a dominant share by the end of the forecast period
• The Asia Pacific market emerged as the dominant region in 2020 and is projected to register the highest CAGR over the forecast period

Access Press Release@ https://www.grandviewresearch.com/press-release/global-automotive-semiconductor-market

Automotive Semiconductor Market Segmentation

Grand View Research has segmented the global automotive semiconductor market based on component, vehicle type, application, and region:

Automotive Semiconductor Component Outlook (Revenue, USD Million, 2017 - 2028)

• Processor
• Discrete Power
• Sensor
• Memory
• Others

Automotive Semiconductor Vehicle Type Outlook (Revenue, USD Million, 2017 - 2028)

• Passenger Vehicle
• Light Commercial Vehicle (LCV)
• Heavy Commercial (HCV)

Automotive Semiconductor Application Outlook (Revenue, USD Million, 2017 - 2028)

• Chassis
• Powertrain
• Safety
• Telematics & Infotainment
• Body Electronics

Automotive Semiconductor Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (MEA)

List of the Key Players in the Automotive Semiconductor Market

• Analog Devices, Inc.
• Infineon Technologies AG
• NXP Semiconductors
• Renesas Electronics Corporation
• Robert Bosch GmbH
• ROHM CO., LTD.
• Semiconductor Components Industries, LLC
• STMicroelectronics
• Texas Instruments Incorporated
• TOSHIBA CORPORATION

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

India Electric Vehicle Market Overview And Rising Dependency On Factors 2021– 2030: Grand View Research Inc.

 India Electric Vehicle Market Growth & Trends

The India electric vehicle market size is expected to reach USD 152.21 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 94.4% from 2021 to 2030. The stringent regulations being drafted by the Indian government in response to the rising levels of vehicular emissions and the growing demand for environment-friendly vehicles are expected to drive the growth of the market over the forecast period. The efforts being pursued by the government to develop sustainable charging infrastructure in India also bodes well for the growth of the market.

Although the electric vehicle market in India is in its nascent stages at present, it is poised to emerge as one of the leading electric vehicle markets in the world. The Indian government has been pursuing consistent and committed efforts and has already drafted dedicated EV policies and rolled out various demand and supply incentives as part of the efforts to encourage the adoption of e-mobility across various market segments. For instance, India’s Department of Heavy Industry (DHI), under the National Electric Mobility Mission Plan (NEMMP) 2020, has formulated the Faster Adoption and Manufacturing of Electric Vehicles (FAME) scheme to support the development of both Hybrid Vehicles (HV) and Electric Vehicle (EV) markets as well as that of their manufacturing eco-systems.

The growing popularity of electric vehicles is prompting the leading automotive manufacturers to launch electric vehicles in India. For instance, in October 2019, Maruti Suzuki, a leader in the conventional vehicle market, announced plans to launch electric vehicles for personal use for the Indian market in the following years. Similarly, in August 2021, Tata Motors launched the Tata Tigor EV in the Indian market. As the market continues to evolve and the consumer preference continues to shift from conventional vehicles to electric vehicles, more and more conventional vehicle manufacturers are expected to launch electric vehicles in the Indian market, thereby driving the growth of the market over the forecast period.

The outbreak of the COVID-19 pandemic triggered a global economic slowdown. The electric vehicle market is particularly vulnerable to any global economic slowdown owing to its reliance on global sourcing for the core battery technology. Moreover, the initial purchase price of electric vehicles tends to be higher than the gasoline-fired and hybrid vehicles, which particularly restrains the adoption of electric vehicles among price-sensitive customers. However, the Indian electric vehicle (EV) market was unaffected by the outbreak of the pandemic. In India, the registration of new electric passenger cars increased by 109% y/y in 2020, with 5,905 new vehicle registrations noted during the year.

Request a free sample copy or view report summary: India Electric Vehicle Market Report

India Electric Vehicle Market Report Highlights

• In terms of product, the BEV segment dominated the market in 2020 and is anticipated to value at USD 116.80 billion by 2030. This can be attributed to the increasing preference of consumers towards EVs over ICE vehicles and restrictions on vehicular CO2 emissions
• The passenger cars segment is expected to expand at the highest CAGR of around 106% over the forecast period. The growth can be attributed to increasing investments by the government in EV infrastructure, along with tax benefits offered to consumers
• The rising popularity of electric vehicles is prompting the leading automotive manufacturers to launch electric vehicles in India, which is anticipated to create growth opportunities for the market in the country

Access Press Release@ https://www.grandviewresearch.com/press-release/india-electric-vehicle-market-analysis

India Electric Vehicle Market Segmentation

Grand View Research has segmented the India electric vehicle market based on product and vehicle type:

India Electric Vehicle Product Outlook (Volume, Units; Revenue, USD Million, 2016 - 2030)

• BEV
• PHEV

India Electric Vehicle Type Outlook (Volume, Units; Revenue, USD Million, 2016 - 2030)

• Passenger Cars
• Commercial Vehicles

List of Key Players in the India Electric Vehicle Market

• Audi AG
• BMW AG
• Hyundai Motor India
• Jaguar Land Rover Limited
• Mahindra & Mahindra Ltd
• Mercedes-Benz AG
• MG Motor India Pvt. Ltd.
• Olectra Greentech Limited
• Tata Motors
• Toyota Motor Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Restaurant Point Of Sale Solution Market is Anticipated to Upgrade USD 4.74 Billion Revenue By 2028: Grand View Research Inc.

 U.S. Restaurant Point Of Sale Solution Market Growth & Trends

The U.S. restaurant point of sale solution market size is expected to reach USD 4.74 billion by 2028, expanding at a CAGR of 3.9% from 2021 to 2028, according to the new study conducted by Grand View Research, Inc. The rising demand for digital solutions for effectively managing restaurant business operations such as tracking employee attendance, inventory, online food order delivery status, and recording orders and sales is expected to drive the market growth.

However, the COVID-19 pandemic severely impacted the restaurant industry, disrupted the supply chain of the point of sale(POS) terminal market, and restricted people in their homes. These factors impacted fine-dine restaurants, affecting the overall demand for POS solutions. As of February 2021, nearly 110,000 restaurants in the U.S. had closed permanently. The pandemic also highlighted the need for improving POS solutions as small and medium-size restaurants were compelled to adopt digital services and embrace automation. Moreover, the concept of cloud kitchens started gaining immense popularity as it allowed businesses to capitalize on the rise in online food orders, boosting the demand for mobile terminals in these premises.

The growing need for contactless transactions, device upgrades, and the readiness of digital payments facilitating quick integration and sync with active accounts are expected to drive the demand for restaurant POS solutions. Furthermore, reduction in Total Cost of Ownership (TCO) and improved return on investments offered by the POS terminals have considerably increased their demand among SMBs. Also, the introduction to PIN and chip-embedded payment cards has reduced security concerns, thereby controlling sensitive data theft and augmenting demand for POS solutions.

The introduction of mobile payment applications has also fueled the demand for software solutions as cashless payments are gaining immense popularity among consumers. Merchants have started accepting mobile wallet payments via applications such as PayPal, Venmo, Samsung Pay, Google Pay, and Apple Pay. Along with facilitating cashless payment, contactless payment methods also helped limit the spread of COVID-19, which increased their popularity. Moreover, the availability of technologically advanced POS payment applications and terminals is expected to augment the demand for POS solutions in the restaurant industry.

Request a free sample copy or view report summary: U.S. Restaurant Point Of Sale Solution Market Report

U.S. Restaurant Point Of Sale Solution Market Report Highlights

• In terms of component, the software segment is expected to expand at the highest CAGR from 2021 to 2028. The demand for POS software has increased during the COVID-19 pandemic as restaurateurs adopted mobile POS terminals and upgraded their existing applications to support online food deliveries
• In terms of product, the mobile POS segment is expected to exhibit the highest growth rate owing to benefits such as affordability, quick integration, and mobility. Advanced mPOS software solutions are also equally capable of handling inventory, financial transactions, and sales information to support business operations
• In terms of end user, the FSR segment dominated the market in 2020 owing to the high demand for POS solutions across fine-dine and casual-dine restaurants. However, the FSR segment suffered significant losses in 2020 as the COVID-19 pandemic impacted the restaurant industry. The industry is recovering slowly in 2021 as many restaurants have reopened, expected to help the segment expand in the near future
• NCR Corporation; Toast Inc.; Square Inc.; Clover Network Inc.; and Oracle are some of the prominent players in the market. These vendors have created a strong ecosystem of distributors, technology, and channel partners in the country, driving the market growth.

Access Press Release@ https://www.grandviewresearch.com/press-release/us-restaurant-point-of-sale-solution-market-analysis

U.S. Restaurant Point Of Sale Solution Market Segmentation

For this study, Grand View Research has segmented the U.S. restaurant POS solution market based on product, component, deployment, and end-user:

U.S. Restaurant POS Solution Product Outlook (Revenue, USD Million, 2017 - 2028)

• Fixed POS
• Mobile POS

U.S. Restaurant POS Solution Component Outlook (Revenue, USD Million, 2017 - 2028)

• Hardware
• Software
• Services

U.S. Restaurant POS Solution Deployment Outlook (Revenue, USD Million, 2017 - 2028)

• Cloud
• On-premises

U.S. Restaurant POS Solution End-user Outlook (Revenue, USD Million, 2017 - 2028)

• FSR
  • Fine Dine
  • Casual Dine
• QSR
• Institutional
• Others

List of Key Players of the U.S. Restaurant Point Of Sale Solution Market

• Ingenico (acquired by Worldline)
• PAX Technology
• Clover Network Inc.
• Lightspeed
• Square Inc.
• TouchBistro
• Toast, Inc.
• Helcim Inc.
• Revel System
• Bepoz America LLC
• Oracle

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Shingles Vaccine Market to Witness Exponential Growth by 2028: Grand View Research Inc.

 Shingles Vaccine Market Growth & Trends

The global shingles vaccine market size is expected to reach USD 6.35 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.9% from 2021 to 2028. Increasing incidence of shingles and high awareness regarding shingles in developed countries are contributing to the market growth. According to the CDC, nearly one million cases of shingles are reported each year in the United States. Furthermore, one out of three individuals in the country will develop the disease in their lifetime.

The increasing adoption of vaccines and an increase in the recommendation of vaccination by different government regulatory bodies are expected to drive the market over the forecast period. For instance, in February 2019, the U.K. Joint Committee of Vaccination and Immunization (JCVI) has recommended the use of the recombinant vaccine to prevent shingles in adults aged 60 to 70 years old.

The inclusion of shingles vaccines in national immunization programs of several countries is anticipated to propel the demand for vaccines. For instance, the shingles vaccine is a part of the national immunization program in the U.K. since 2013. The U.K. is the first country in the European region to introduce shingles vaccine in the national immunization program and it costs around USD 130 to the National Health Service (NHS) for each dose of the vaccine. Similarly, other countries such as the U.S., Italy, Australia, and some provinces of Canada and South Korea have also included the vaccine in their immunization program.

Besides, favorable initiatives undertaken by market players and regulatory bodies to increase the awareness among people who are at risk of developing the disease are expected to fuel the market growth over the coming years. For instance, GlaxoSmithKline plc. has launched a campaign to increase vaccination rates among older adults by educating people about the benefits associated with vaccination.

The high efficacy of vaccines is expected to increase the adoption over the forecast period. According to clinical trial results, Shingrix is highly efficient to prevent shingles and postherpetic neuralgia. Two doses of Shingrix are more than 90% effective to prevent the disease in adults aged 50 years and above. Protection stays above 85% for at least the first four years after getting vaccinated.

The availability of vaccines at lower prices, coupled with a high incidence of the disease and high vaccination rate in developed countries, is anticipated to fuel the market growth. The vaccination rate against shingles in the U.K., the U.S., France, Canada, Germany, and South Korea is higher compared to other countries owing to better reimbursement policies and high awareness levels regarding the disease and vaccines. For instance, the U.K. has the highest shingles vaccine uptake with more than 60% vaccination of eligible adults.

Request a free sample copy or view report summary: Shingles Vaccine Market Report

Shingles Vaccine Market Report Highlights

• By product, Shingrix held the largest share in 2020 owing to the high efficacy of the vaccine as compared to others. Shingrix is also expected to grow at a significant CAGR over the forecast period owing to the increasing recommendations by regulatory bodies to prevent shingles
• Based on vaccine type, the recombinant vaccine segment is anticipated to grow at a substantial rate over the forecast period due to the low risk associated with recombinant vaccines
• Asia Pacific is projected to witness the fastest growth during the forecast period owing to the high unmet needs and the rising adoption of vaccination programs in the region
• North America dominated the market in 2020 due to favorable reimbursement policies and rising initiatives to raise awareness among healthcare professionals and patients

Access Press Release@ https://www.grandviewresearch.com/press-release/global-shingles-vaccine-market

Shingles Vaccine Market Segmentation

Grand View Research has segmented the global shingles vaccine market on the basis of product, vaccine type, and region:

Shingles Vaccine Product Outlook (Revenue, USD Million, 2017 - 2028)

• Shingrix
• Zostavax
• SkyZoster

Shingles Vaccine Type Outlook (Revenue, USD Million, 2017 - 2028)

• Recombinant Vaccine
• Live Attenuated Vaccine

Shingles Vaccine Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

List of Key Players of Shingles Vaccine Market

• GlaxoSmithKline plc.
• SK chemicals
• Green Cross Corp
• CanSinoBIO
• Geneone Life Science
• Vaccitech

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Clinical Trial Supply And Logistics Market to Reap Excessive Revenues By 2028

 Clinical Trial Supply And Logistics Market Growth & Trends

The global clinical trial supply and logistics market size is expected to reach USD 5.4 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.1% from 2021 to 2028. The market growth is attributed to the increasing need to manage clinical trials and innovations and technology advancements in clinical trial supply and logistics services

However, the COVID-19 pandemic had a negative impact on the market due to restrictions imposed by countries, which led to a 95% reduction in commercial airlines. Besides, clinical trials have increased due to the rising demand for the Covid-19 vaccine. According to the WHO, more than 80 vaccines are currently being studied in clinical trials, with over 180 in the pre-clinical stage. There would be a challenge for logistics related to timelines and access to a large population.

Digitalization tools are required to overcome these challenges for future trials. For instance, a kit with a scannable label can be monitored throughout the supply chain from the kit assembly line to the patient’s home. Machine learning algorithms can take the process a step further by considering various factors across multiple supply chains, such as capacity or hours of service. Radio-frequency identification (RFID) can also aid in the management of shipments required for these clinical trials.

Request a free sample copy or view report summary: Clinical Trial Supply And Logistics Market Report

Clinical Trial Supply And Logistics Market Report Highlights

• The logistics and distribution service segment dominated the market in 2020 with a revenue share of over 20.0% owing to an increase in clinical trials as a result of Covid-19
• Based on phase, the phase III segment dominated the market with a revenue share of over 40.0% in 2020
• In terms of end-user, the pharmaceuticals segment held the largest revenue share of over 40.0% in 2020. This is due to the investment by companies and the presence of a large number of players in the market
• By therapeutic area, the cardiovascular diseases segment dominated the market with a revenue share of over 25.0% in 2020 due to an increase in the number of cardiovascular research studies and firms focused on bringing innovative drugs to the market
• Asia Pacific is anticipated to register the fastest growth rate of 7.8% throughout the forecast period. The region has access to a large and diversified patient pool, cheaper recruitment costs, and favorable policies that make Asia Pacific desirable for clinical trials

Access Press Release@ https://www.grandviewresearch.com/press-release/global-clinical-trial-supply-logistics-market

Clinical Trial Supply And Logistics Market Segmentation

Grand View Research has segmented the global clinical trial supply and logistics market based on service, phase, end-user, therapeutic area, and region:

Clinical Trial Supply And Logistics Service Outlook (Revenue, USD Million, 2016 - 2028)

• Logistics & Distribution
• Storage & Retention
• Packaging, Labeling, and Blinding
• Manufacturing
• Comparator Sourcing
• Other Services (Solutions, Ancillary Supply)

Clinical Trial Supply And Logistics Phase Outlook (Revenue, USD Million, 2016 - 2028)

• Phase I
• Phase II
• Phase III
• Phase IV

Clinical Trial Supply And Logistics End-user Outlook (Revenue, USD Million, 2016 - 2028)

• Pharmaceuticals
• Biologicals
• Medical Device

Clinical Trial Supply And Logistics Therapeutic Area Outlook (Revenue, USD Million, 2016 - 2028)

• Oncology
• Cardiovascular Diseases
• Respiratory Diseases
• CNS and Mental Disorders
• Others

Clinical Trial Supply And Logistics Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Iran
  • Israel

List of Key Players of Clinical Trial Supply And Logistics Market

• Thermo Fisher Scientific (Patheon)
• Catalent, Inc.
• Parexel
• Almac Group
• Marken
• Piramal Pharma Solutions 
• UDG Healthcare
• DHL
• FedEx
• Movianto
• Packaging Coordinators Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Demand for Europe Pharmaceutical Market Increasing in Most Part of World 2028

 Europe Pharmaceutical Market Growth & Trends

The Europe pharmaceutical market size is expected to reach USD 432.12 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.4% from 2021 to 2028. The market is driven by an increasing prevalence of diseases, a growing elderly population, and the approval and launch of novel products in the European region.

Overall, the pharmaceutical market in Europe is dominated by branded drugs; however, the generic drugs segment is anticipated to grow at the fastest rate over the forecast period. Loss of patent protection of key pharmaceutical products and increasing government initiatives to adopt generic drugs for the treatment are some of the key factors likely to boost generics demand in the coming years.

The capitalization opportunity is high for generic manufacturers in the European market as governments from each region are forming plans to meet the population’s demand and lower healthcare-associated expenditure of the country. The expiration of patent exclusivities and the building need for cost-effective treatments are fueling the penetration of biosimilars and generics.

Novel molecule entry in this market typically takes 12-13 years and an investment of over USD 2.5 billion. In 2019, the total R&D expenditure on pharmaceutical R&D was USD 44,881.92 million. Increased competition from growing economies, such as China and Brazil, has accelerated the European economic investment in research to maintain its dominance in the market.

Improvements in healthcare infrastructure are promoting the adoption of novel pharmaceuticals. Furthermore, an increase in drug launches in Europe is projected to propel the market growth. For instance, in 2020, 62 drugs were approved in Europe and 97 medicines received marketing approval in European countries. The highest number of drug approvals were observed in the oncology segment.

Key pharmaceutical companies offer strong branded drugs in multiple therapeutic segments. Increasing R&D efforts, the growing adoption of novel therapies, and strategic collaborations are likely to boost the penetration of branded drugs. Strong pipeline products in different therapeutic areas are likely to fuel the growth of branded drugs in Europe.

Request a free sample copy or view report summary: Europe Pharmaceutical Market Report

Europe Pharmaceutical Market Report Highlights

• By therapeutic category, the oncology segment is expected to grow at the fastest rate owing to the increasing prevalence of cancer along with the entry of novel molecules into the market
• Based on product, generic drugs are expected to emerge as the fastest-growing segment over the forecast period owing to the increased preference of the consumers for generic drugs due to their cost-effectiveness
• In terms of type, the prescription segment held the largest share in 2020 owing to the presence of the majority of pharmaceuticals in the prescription category
• Western Europe held the largest share in 2020 owing to the presence of countries with developed healthcare systems
• The preference of companies for contract manufacturing is rising in Europe due to the specialized nature of pharmaceutical products and reasonable production costs

Access Press Release@ https://www.grandviewresearch.com/press-release/europe-pharmaceutical-market-analysis

Europe Pharmaceutical Market Segmentation

Grand View Research has segmented the Europe pharmaceutical market based on product, type, therapeutic category, and region:

Europe Pharmaceutical Product Outlook (Revenue, USD Billion, 2017 - 2028)

• Branded
• Generic

Europe Pharmaceutical Type Outlook (Revenue, USD Billion, 2017 - 2028)

• OTC
• Prescription

Europe Pharmaceutical Therapeutic Category Outlook (Revenue, USD Billion, 2017 - 2028)

• Oncology
• Cardiovascular Diseases
• Anti-infectives
• Central Nervous System Disorders
• Metabolic Disorders
• Gastrointestinal Disorders
• Respiratory Diseases
• Other Disorders

Europe Pharmaceutical Regional Outlook (Revenue, USD Billion, 2017 - 2028)

• Western Europe
  • UK.
  • France
  • Germany
  • Italy
  • Spain
• Central & Eastern Europe
  • Poland
  • Hungary
  • Switzerland
• Nordic Regions
  • Denmark
  • Finland
  • Norway
• Rest of Europe

List of Key Players of Europe Pharmaceutical Market

• Hoffmann-La Roche Ltd.
• Bristol-Myers Squibb Company
• AstraZeneca plc
• Novartis AG
• Johnson & Johnson Services, Inc.
• Gilead Sciences, Inc.
• GlaxoSmithKline plc.
• Merck & Co., Inc.
• Pfizer Inc.
• Sanofi
• Boehringer Ingelheim GmbH

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Chloroprene Rubber Market Witness Excellent Revenue Growth During 2021-2028: Grand View Research Inc

 Chloroprene Rubber Market Growth & Trends

The global chloroprene rubber market size is expected to reach USD 1.39 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 4.6% from 2021 to 2028. Increasing adoption of chloroprene rubber in the automotive, electrical & electronics, construction, and textile industries is projected to fuel the market growth during the forecast period. It is widely used in tire sidewalls, automotive trims, gaskets, and related products owing to the rising demand for Electric Vehicles (EVs).

The growing requirement for electrical power is expected to drive the demand for electric cables for power transmission. This is expected to drive the product demand in cable jackets. The rising private & public investments in the construction sector focusing on the development of infrastructure projects across the globe remain critical to the product demand in construction applications. The product has a wide scope of application in the manufacture of rubber pads products due to the demand arising from the construction industry.

Major key players in the market are investing in expanding and developing chloroprene for end-use industries. For instance, in April 2021, ARLANXEO established ARLANXEO India Private Limited in India to strengthen its position in the Indian market to meet the needs of quickly expanding industries, such as pharmaceuticals, tires, automotive, and end-user products.

The demand for industrial products and chemicals in countries such as China, Japan, India, South Korea, and Thailand is expected to impact the consumption of chloroprene rubber used in these products. Many elastomer manufacturers are carrying out research and development activities to develop a vulcanization process for manufacturing chloroprene rubber to replace the existing smoked rubber suppression technique. One of the main advantages offered by the vulcanization process is the improvement in absorbent properties. This has helped position chloroprene rubber as a suitable material for manufacturing protective lining in chemical plants.

Request a free sample copy or view report summary: Chloroprene Rubber Market Report

Chloroprene Rubber Market Report Highlights

• In terms of revenue, the automotive application segment accounted for the largest revenue share of more than 35% in 2020. It is expected to grow further at a steady CAGR over the forecast period
• Asia Pacific was the largest regional market in 2020 and accounted for more than 50.0% of the global revenue share
• China was the largest producer of vehicles in the Asia Pacific. Rising consumer disposable income levels in the country coupled with the high demand for EVs and luxury cars will; boost the product demand in automotive applications in China
• Various strategic initiatives were recorded over the past few years to boost the growth of the market
• For instance, in August 2020, Tosoh Corporation collaborated with Bando Chemicals to develop cost-reducing technology for manufacturing CNF-reinforced chloroprene rubber to be used in transmission belts in the automobile sector

Access Press Release@ https://www.grandviewresearch.com/press-release/global-chloroprene-rubber-market

Chloroprene Rubber Market Segmentation

Grand View Research has segmented the global chloroprene rubber market on the basis of application and region:

Chloroprene Rubber Application Outlook (Volume, Kilotons; Revenue, USD Million, 2017 - 2028)

• Automotive
• Electrical & Electronics
• Construction
• Textile
• Others

Chloroprene Rubber Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2017 - 2028)

• North America
  • US.
• Europe
  • Germany
• Asia Pacific
  • China
  • India
  • Japan
• Central & South America
• Middle East & Africa

List of Key Players of the Chloroprene Rubber Market

• Tosoh Corp.
• Denka Company Ltd.
• ARLANXEO
• SEDO Chemicals Neoprene GmbH
• QingDao Nova Rubber

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Neurology Clinical Trials Market Set to Witness an Uptick during 2021 to 2028: Grand View Research Inc.

 Neurology Clinical Trials Market Growth & Trends

The global neurology clinical trials market size is expected to reach USD 7.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.5% from 2021 to 2028. This is largely attributed to big pharma companies conducting innovative trials in neurology, increased government funding from the National Institute of Neurological Disorders and Stroke (NINDS), and stringent regulatory requirements pertaining to clinical trials. 

Neuroscience continues to receive a healthy level of early investment. It received USD 1.5 billion in venture capital funding in 2018, second only to cancer, indicating that investors expect a large pharma acquisition to pay off in the near future. As the industry strives to move past the many late-stage clinical failures of recent years, early diagnosis of diseases is attracting investment and driving deal-making in the complex neuroscience sector, particularly for pain and Alzheimer's disease.

In terms of deal volume, no other therapy area comes close to matching oncology, but neuroscience is among the nearest contenders. Despite a drop in total expected value in 2017, the number of neuroscience-related licensing deals has gradually climbed over the last decade. The vast majority of neuroscience agreements ~90%have a primary neurological focus, which corresponds to the level of R&D activity in the two disciplines.

Many experimental therapeutics require dosage by on-site administration and carefully scheduled outcome measure evaluations hence, the COVID-19 pandemic has significantly harmed the implementation of the precise procedures required to establish proof of safety and efficacy. The COVID-19 has resulted in the shutdown of the network of centers conducting stroke clinical trials. This was followed by a phased research restart plan that took local circumstances and regulatory oversight into account. This approach was successful in a reengaging research effort to some extent in all but one of the ongoing investigations within 55 days.

Request a free sample copy or view report summary: Neurology Clinical Trials Market Report

Neurology Clinical Trials Market Report Highlights

• The phase II segment dominated the market and accounted for a maximum revenue share of 36.7% in 2020. Between 1999 and 2020, 8,205 CNS trials were conducted, with 609 trials being conducted in 2020
• The interventional segment held the largest market revenue share of 81.1% in 2020
• The Huntington's disease segment is anticipated to register the fastest CAGR of 6.0% over the forecast period. This is largely due to the high prevalence of the disease around the world
• North America dominated the market and accounted for a revenue share of 45.8% in 2020. The rising prevalence of neurological disorders and the presence of a large number of players in clinical trials drive the market in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-neurology-clinical-trials-market

Neurology Clinical Trials Market Segmentation

Grand View Research has segmented the global neurology clinical trials market based on phase, study design, indication, and region:

Neurology Clinical Trials Phase Outlook (Revenue, USD Million, 2016 - 2028)

• Phase I
• Phase II
• Phase III
• Phase IV

Neurology Clinical Trials Study Design Outlook (Revenue, USD Million, 2016 - 2028)

• Interventional
• Observational
• Expanded Access

Neurology Clinical Trials Indication Outlook (Revenue, USD Million, 2016 - 2028)

• Epilepsy
• Parkinson's Disease (PD)
• Huntington's Disease
• Stroke
• Traumatic Brain Injury (TBI)
• Amyotrophic Lateral Sclerosis (ALS)
• Muscle regeneration
• Others

Neurology Clinical Trials Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Neurology Clinical Trials Market

• IQVIA
• Novartis
• Covance
• Medpace
• Charles River Laboratories
• Syneous Health
• Icon Plc
• GlaxoSmithKline
• Aurora healthcare
• Biogen

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Current And Future Market Conditions 2021-2028: Grand View Research Inc.

 In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Growth & Trends

The global in-vitro toxicology assays market size for cannabis and nicotine testing is expected to reach USD 2.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.2% from 2021 to 2028. Growing adoption of high throughput techniques in cannabis testing, legalization of medical cannabis, and growing awareness regarding the potential hazards of nicotine consumption have majorly driven the market throughout the forecast period.

The legalization of medical cannabis is underway globally, including in countries such as Germany, Australia, and Israel. The market is gaining momentum in the Asia Pacific region, with Thailand having fully legalized medicinal cannabis. Thus, increasing legalization of medical cannabis is expected to drive the market growth to a major extend. In addition, technological advancements in cellular assays have boosted the market growth.

COVID-19 has become a catalyst for changing the traditional use of cannabis. Owing to the pandemic, the leading scientific community and market competitors are now focusing on deciphering the potential of cannabis to prevent SARS-CoV-2 infection. Companies have reported the increase in the sale of cannabis as some states/countries have declared cannabis as an essential medicine during the pandemic.

Request a free sample copy or view report summary: In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Report

In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Report Highlights

• Nicotine testing accounted for the largest revenue in 2020 and is expected to continue the trend in the forecast period owing to increasing safety concerns associated with nicotine products
• Cannabis testing is expected to witness gradual growth through 2021-2028 owing to the rising acceptance of cannabis for medical use
• 3D cell culture technology is expected to grow at substantial CAGR owing to the increasing popularity of drug development and toxicity testing
• Cytotoxicity testing designing accounted for the highest market revenue in 2020 owing to advancements in different tools for evaluating the cytotoxic effects of nicotine-containing products
• North America has emerged as the highest revenue-generating region in 2020, owing to the prevalence of cancer, presence of key players, and developed healthcare infrastructure
• Asia Pacific is anticipated to witness the fastest CAGR throughout the forecast period. It is anticipated that China and India are contributing majorly to the regional market’s growth
• Key players are undertaking various strategic initiatives such as mergers and acquisitions to maintain their presence in the market
• In August 2020, Eurofins Scientific purchased approximately 136 smaller labs within 3 years from 2014 to 2019, accounting for a total expenditure of USD 3.4 billion in these acquisitions

Access Press Release@ https://www.grandviewresearch.com/press-release/global-in-vitro-toxicology-assays-cannabis-nicotine-testing-market

In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Segmentation

Grand View Research has segmented the global in-vitro toxicology assays market for cannabis and nicotine testing on the basis of test type, technology, application, method, and region:

In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Type Outlook (Revenue, USD Million, 2017 - 2028) 

• Cannabis Testing
• Nicotine Testing

In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Technology Outlook (Revenue, USD Million, 2017 - 2028)

• 3D Cell Culture Technology
• Mass Spectrometry
• Flow Cytometry
• Others

In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Application Outlook (Revenue, USD Million, 2017 - 2028)

• Genetic Toxicity Testing
• Carcinogenicity Testing
• Cytotoxicity Testing
• Mutagenicity Testing
• Others

In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Method Outlook (Revenue, USD Million, 2017 - 2028)

• Cellular Assay
  • Live Cells
    • High Throughput / High Content Screening
    • Molecular Imaging
    • Others
  • Fixed Cells
• Others

In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Spain
  • Italy
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of In-vitro Toxicology Assays Market For Cannabis And Nicotine Testing

• Stemina Biomarker Discovery, Inc.
• Broughton Nicotine Services
• Labstat International, Inc.
• IONTOX
• TOXIKON
• Integrated Laboratory Systems
• Enthalpy Analytical
• PBR Laboratories, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Extracorporeal CO2 Removal Devices Market Trends, Demand, Production, Analysis and Forecast to 2028: Grand View Research Inc.

 Extracorporeal CO2 Removal Devices Market Growth & Trends

The global extracorporeal CO2 removal devices market size is estimated to reach USD 118.64 million by 2028, registering a CAGR of 5.27% over the forecast period, according to a new report by Grand View Research, Inc. Technological improvements have changed extracorporeal techniques for CO2 removal in a promising manner to avoid respiratory failure, worsening respiratory acidosis, and to possibly shorten or prevent the duration of invasive mechanical ventilation in patients with exacerbation of asthma and Chronic Obstructive Pulmonary Disease (COPD).

Extracorporeal CO2 removal devices are considered to be an efficient therapy for patients suffering from hypercapnia respiratory failure and may allow clinicians as well as healthcare professionals to improve lung-protective ventilation. These devices can remove adequate CO2 to allow a 50% reduction in alveolar minute ventilation resulting in a substantial reduction in PaCO2. Hence, various advantages associated with these devices are expected to augment the overall market growth.

Extracorporeal CO2 removal devices are effective, safe, and feasible. The usage of these tools in ventilation support has been suggested in clinical situations where they may be useful, including exacerbation of COPD and Acute Respiratory Distress Syndrome (ARDS). The increasing prevalence of COPD across the globe is predicted to accelerate market growth. According to the British Lung Association, around 1.2 million people are diagnosed with COPD in the U.K.

Several manufacturers in the market are focusing on developing technologically advanced and innovative devices to strengthen their industry position. For instance, in November 2015, Alung Technologies received an Expedited Access Pathway (EAP) from the FDA for its Hemolung Respiratory Assist System (RAS). In February 2016, Alung Technologies received USD 12 million financing from existing as well as new investors. This financing helped in the commercialization of Hemolung RAS.

Request a free sample copy or view report summary: Extracorporeal CO2 Removal Devices Market Report

Extracorporeal CO2 Removal Devices Market Report Highlights

• Extracorporeal CO2 machines held the largest revenue share of the global market in 2020 owing to the availability of a wide range of devices
• The COPD application segment accounted for a significant revenue share of the global market in 2020
• The venovenous access segment is expected to account for the largest share by 2028 due to advantages, such as decreased invasiveness, and potential for the early mobilization of patients
• The hospitals end-use segment is estimated to have the fastest CAGR over the forecast period due to the rising number of hospitals in developing economies and increasing competition in healthcare service providers
• North America held the largest market share in 2020 and is anticipated to maintain its dominance over the forecast period
• This is attributable to the growing prevalence of COPD & ARDS and the increasing adoption of advanced devices

Access Press Release@ https://www.grandviewresearch.com/press-release/global-extracorporeal-co2-removal-devices-market

Extracorporeal CO2 Removal Devices Market Segmentation

Grand View Research has segmented the global extracorporeal CO2 removal devices market on the basis of product, application, access, end use, and region:

Extracorporeal CO2 Removal Devices Product Outlook (Revenue, USD Million, 2016 - 2028)

• Extracorporeal CO2 Machines
• Disposables
• Others

Extracorporeal CO2 Removal Devices Application Outlook (Revenue, USD Million, 2016 - 2028)

• ARDS
• COPD
• Bridge to Lung Transplant
• Others

Extracorporeal CO2 Removal Devices Access Outlook (Revenue, USD Million, 2016 - 2028)

• Venovenous
• Arteriovenous

Extracorporeal CO2 Removal Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Clinics
• Others

Extracorporeal CO2 Removal Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Extracorporeal CO2 Removal Devices Market

• Medtronic
• Getinge AB
• Xenios AG
• Alung Technologies
• ESTOR SpA
• Medica SpA
• Aferectica Srl

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.